The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flores, I.
Right arrow Articles by Mérida, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flores, I.
Right arrow Articles by Mérida, I.
The Journal of Immunology, 1999, 163: 708-714.
Copyright © 1999 by The American Association of Immunologists

Diacylglycerol Kinase Inhibition Prevents IL-2-Induced G1 to S Transition Through a Phosphatidylinositol-3 Kinase-Independent Mechanism1

Ignacio Flores, David R. Jones, Angel Ciprés, Ernesto Díaz-Flores, Miguel Angel Sanjuan and Isabel Mérida2

Department of Immunology and Oncology, Centro Nacional de Biotecnología, Campus de Cantoblanco, Madrid, Spain

Stimulation via IL-2R ligation causes T lymphocytes to transit through the cell cycle. Previous experiments by our group have demonstrated that, in human T cells, IL-2 binding induces phosphatidic acid production through activation of the {alpha} isoform of diacylglycerol kinase. In this study, using the IL-2-dependent mouse T cell line CTLL-2, we demonstrate that pharmacological inhibition of IL-2-induced diacylglycerol kinase activation is found to block IL-2-induced late G1 to S transition without affecting cell viability. Herein, we demonstrate that diacylglycerol kinase inhibition has a profound effect on the induction of the protooncogenes c-myc, c-fos, and c-raf by IL-2, whereas expression of bcl-2 and bcl-xL are not affected. When the IL-2-regulated cell cycle control checkpoints are examined in detail, we demonstrate that inhibition of diacylglycerol kinase activation prevents IL-2 induction of cyclin D3 without affecting p27 down-regulation. The strict control of cell proliferation exerted by phosphatidic acid through activation of diacylglycerol kinase is independent of other well-characterized IL-2R-derived signals, such as the phosphatidylinositol-3 kinase/Akt pathway, indicating the existence of a different and important mechanism to control cell division.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Matsubara, Y. Shirai, K. Miyasaka, T. Murakami, Y. Yamaguchi, T. Ueyama, M. Kai, F. Sakane, H. Kanoh, T. Hashimoto, et al.
Nuclear Transportation of Diacylglycerol Kinase {gamma} and Its Possible Function in the Nucleus
J. Biol. Chem., March 10, 2006; 281(10): 6152 - 6164.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Bacchiocchi, G. Baldanzi, D. Carbonari, C. Capomagi, E. Colombo, W. J. van Blitterswijk, A. Graziani, and F. Fazioli
Activation of {alpha}-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase
Blood, September 15, 2005; 106(6): 2175 - 2182.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Avila-Flores, T. Santos, E. Rincon, and I. Merida
Modulation of the Mammalian Target of Rapamycin Pathway by Diacylglycerol Kinase-produced Phosphatidic Acid
J. Biol. Chem., March 18, 2005; 280(11): 10091 - 10099.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Cipres, S. Carrasco, E. Merino, E. Diaz, U. M. Krishna, J. R. Falck, C. Martinez-A, and I. Merida
Regulation of Diacylglycerol Kinase {alpha} by Phosphoinositide 3-Kinase Lipid Products
J. Biol. Chem., September 12, 2003; 278(37): 35629 - 35635.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Sanjuan, B. Pradet-Balade, D. R. Jones, C. Martinez-A, J. C. Stone, J. A. Garcia-Sanz, and I. Merida
T Cell Activation In Vivo Targets Diacylglycerol Kinase {alpha} to the Membrane: A Novel Mechanism for Ras Attenuation
J. Immunol., March 15, 2003; 170(6): 2877 - 2883.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Zhou, F. Zhang, and T. M. Aune
Either IL-2 or IL-12 Is Sufficient to Direct Th1 Differentiation by Nonobese Diabetic T Cells
J. Immunol., January 15, 2003; 170(2): 735 - 740.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-P. Zhong, E. A. Hainey, B. A. Olenchock, H. Zhao, M. K. Topham, and G. A. Koretzky
Regulation of T Cell Receptor-induced Activation of the Ras-ERK Pathway by Diacylglycerol Kinase zeta
J. Biol. Chem., August 16, 2002; 277(34): 31089 - 31098.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Velasco-Sampayo and S. Alemany
p27kif Protein Levels and E2F Activity Are Targets of Cot Kinase During G1 Phase Progression in T Cells
J. Immunol., May 15, 2001; 166(10): 6084 - 6090.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. A. Sanjuan, D. R. Jones, M. Izquierdo, and I. Merida
Role of Diacylglycerol Kinase {alpha} in the Attenuation of Receptor Signaling
J. Cell Biol., April 2, 2001; 153(1): 207 - 220.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Aragones, D. R. Jones, S. Martin, M. A. S. Juan, A. Alfranca, F. Vidal, A. Vara, I. Merida, and M. O. Landazuri
Evidence for the Involvement of Diacylglycerol Kinase in the Activation of Hypoxia-inducible Transcription Factor 1 by Low Oxygen Tension
J. Biol. Chem., March 23, 2001; 276(13): 10548 - 10555.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Palicz, T. R. Foubert, A. J. Jesaitis, L. Marodi, and L. C. McPhail
Phosphatidic Acid and Diacylglycerol Directly Activate NADPH Oxidase by Interacting with Enzyme Components
J. Biol. Chem., January 26, 2001; 276(5): 3090 - 3097.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Bregoli, J. J. Baldassare, and D. M. Raben
Nuclear Diacylglycerol Kinase-theta Is Activated in Response to alpha -Thrombin
J. Biol. Chem., June 22, 2001; 276(26): 23288 - 23295.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.